Alnylam Pharmaceuticals (ALNY) Market Cap 2004–2026

As of November 13, 2026, Alnylam Pharmaceuticals had a market cap of $22.09 billion, which increased by 5.34% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.

Data updated: Nov 13, 2026, 4:00 PM ET
Alnylam Pharmaceuticals logo

Alnylam Pharmaceuticals Inc. (ALNY)

🌍 United States 📈 NASDAQ 🏭 Health Care 🏢 Biotechnology
Latest Market Cap
$22.09B ▲ 5.34%
Start of 2026
$52.54B ▼ 57.96%
1 Year Ago
$59.98B ▼ 63.17%
All-Time High
$64.39B ▼ 65.69%


Loading data...

Note: Each point on the chart represents the market capitalization at the end of the trading day.
Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.

📈 Alnylam Pharmaceuticals Market Cap History by Year and Month

Alnylam Pharmaceuticals Market Cap History by Year and Month
Year / MonthMarket Cap% Change
2026$22.09B▼ 57.96%
$22.09B— 0.00%
$22.09B▼ 33.06%
$33B▲ 2.52%
$32.19B▲ 17.10%
$27.49B▼ 31.57%
$40.17B▼ 0.37%
$40.32B▼ 2.35%
$41.29B▼ 5.90%
$43.88B▼ 0.61%
$44.15B▼ 1.14%
$44.66B▼ 15.00%
2025$52.54B▲ 72.70%
2024$30.423B▲ 26.66%
2023$24.02B▼ 17.85%
2022$29.238B▲ 43.46%
All market cap values reflect closing prices for the period shown.

📊 Alnylam Pharmaceuticals Market Cap and Other Industry Peers

Below are selected companies for comparison based on industry, sub-industry, and sector:

  1. $37.26B
  2. $28.61B
  3. $26.57B
  4. $25.06B
  5. $24.68B
  6. $22.09B
  7. $16.96B
  8. $16.88B
  9. $15.35B
  10. $11.42B
  11. $11.32B
  12. $11.08B
  13. $10.88B
  14. $9.93B
  15. $9.46B
  16. $9.17B
  17. $9.04B
  18. $8.54B
  19. $7.97B
  20. $7.81B

Data reflect the most recent market capitalization values available.

Note: Market capitalization figures are based on available sources and may differ slightly from actual values, particularly for historical data.